Williams A, Gutgesell L, de Wet L, Selman P, et al. SOX(2) expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis. Cancer Lett 2023 May 9:216209. doi: 10.1016/j.canlet.2023.216209.
PMID: 37169162